Inspira Technologies (IINN) Preparing Production in Response to Spread of Respiratory Virus in China
-
Inspira Technologies (IINN) Secures a Second U.S. Patent Approval
-
Inspira Technologies (IINN) to Publish HYLA Clinical Results in Fourth Quarter 2024
-
Inspira Technologies (IINN) Announces FDA Listing and Market Readiness of New Product
-
Inspira Technologies (IINN) Israeli Regulatory Approval for the INSPIRA ART100 System
-
Inspira Technologies (IINN) Announces Business Plan Targets
-
Inspira Technologies (IINN) Receives First Ever US Purchase Order for INSPIRA ART100 Systems

